Figure 1. Dalbavancin Structural Formula (Dal04 0004 01)
Dalbavancin Hydrochloride Injection, Powder, For Solution
Product Images NDC 65219-120
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dalbavancin Hydrochloride (NDC 65219-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fresenius Kabi Logo (Dal04 0004 02)
Package Label – Principal Display Panel – Dalbavancin For Injection 500 mg Vial Label (Dal04 0004 03)
This is a description of Dalbavancin, an intravenous antibiotic typically used in hospitals under prescription. It comes in a sterile single-dose vial and should be stored at room temperature. The drug must be reconstituted using either Sterile Water for Injection or 5% Dextrose Injection before infusion. The final solution should not exceed a concentration of 5 mg/mL and should be infused within 48 hours of reconstitution. It is advised not to mix Dalbavancin with other medications or electrolytes during infusion. For full dosage and administration instructions, refer to the prescribing information. The medication is manufactured by Fresenius Kabi.*
Package Label – Principal Display Panel – Dalbavancin For Injection 500 mg Carton Panel (Dal04 0004 04)
This is a description of Dalbavancin for Injection in a 500 mg per vial dose, intended for intravenous infusion. It is contained in a sterile single-dose vial, and any unused portion should be discarded. The package contains one vial, and there is a reference number provided for identification purposes.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
